Sorry, Readability was unable to parse this page for content.
Source: http://feeds.feedburner.com/lern2play
eric decker jr martinez dallas cowboys cheerleaders leftover turkey recipes leftover turkey recipes hugo hugo
Saturday, December 3, 2011
Casting Crowns continue to top Christian charts (AP)
ATLANTA ? Four times a week, Mark Hall ministers to youth at a suburban Atlanta megachurch, working from an office where the walls are lined with vintage Marvel comic books and that also houses a stone-like desk decorated with symbols from "The Avengers."
In Hall's eyes, he's a "dork." But when he steps away from his youth pastor endeavors and comic memorabilia collection, the 42-year-old stars as the lead singer and songwriter of Casting Crowns, a seven-member, Grammy-winning contemporary Christian rock band, one of the most popular in the genre.
In mid-October, the group released their latest album, "Come to the Well." It debuted at No. 2 on Billboard's Top 200 charts, trailing only behind Adele, who has dominated the charts with her best-selling album "21." The band's album also topped the Christian album chart for three weeks in a row.
The band has become accustomed to leading the Christian chart. Their 2009 album, "Until the Whole World Hears," was No. 1 on the chart for 18 weeks.
However, the success doesn't define the band, according to Hall.
"Fame is such an illusion," said Hall, who has been a youth pastor at Eagles Landing First Baptist Church for about 10 years. "If you look at me, I'm just a dork that I've always been. The way I see it, God connected with them (fans) through our song that he let me write. There's no room for me or us to get a big head."
Since the band's debut album in 2003, Casting Crowns has gone platinum three times and gold twice. They've earned a Grammy award for their 2005 album "Lifesong," won five Group of the Year titles at the Dove Awards ? gospel's highest honor ? and they just won an award for Contemporary Inspirational Artist at the American Music Awards this month.
Not bad for a band that does music on a part-time basis.
"I'm extremely thankful for being No. 2 on the charts," said Hall of the band's latest achievement. "It's amazing. I think like probably most musicians, it's something that encourages the moment, but then you have to get back to life."
Along with Hall, who has co-authored three books, the band includes married couple Juan DeVevo (lead guitar) and Melodee DeVevo (violin, backup vocals); Hector Cervantes (guitar); Megan Garrett (piano); Chris Huffman (bass guitar); and Brian Scoggin (drums).
Casting Crowns is known for their aggressive guitar grooves, which center on themes of not giving up and leaning on a higher power. The band's power rock ballads are built on Bible scriptures.
Music is an extension to their individual ministries. All seven members of Casting Crowns remain active in student ministry and tour part-time around their church duties. They lead Bible study group gatherings, head church mission trips and counsel teenagers.
Each of the band members make it an effort to separate their youth ministry endeavors from the Casting Crowns brand. They rarely perform any of the band's songs at worship services on Sundays or use church as a platform announce upcoming concerts or boast about their accolades during service.
Garrett said the youth whom the band ministers to have more important problems in life to worry about than keeping pace with Casting Crowns' achievements.
"A lot of these kids' lives are crumbling," Garrett said. "You have kids whose parents are about to get divorced, some are going through a breakup and some others who are being made fun of at school. The last thing they care about is you having a No. 1 song on the radio. When you're ministering to people, I think it takes the focus off of our self."
And even though it does not seem like Casting Crowns' career is in jeopardy of fading anytime soon, they know that the limelight may not last forever. If that time does come, the band would be able to walk away with contentment.
"When it is over, who are you then?" said Garrett, whose husband is a youth minister at a suburban Atlanta church. "I'm just Megan with all the warts and blemishes that I have. That's the same way for everyone else in the band. We're all just trying to be obedient."
___
Online:
Casting Crowns: http://www.castingcrowns.com
___
Follow Jonathan Landrum Jr. on Twitter at http://www.twitter.com/mrlandrum31
danielle staub last of the mohicans last of the mohicans ryan howard meteor shower 2011 meteor shower 2011 home depot center
After uproar, Ky. church revisits interracial ban (AP)
LOUISVILLE, Ky. ? When Stella Harville brought her black boyfriend to her family's all-white church in rural Kentucky, she thought nothing of it. She and Ticha Chikuni worshipped there whenever they were in town, and he even sang before the congregation during one service.
Then in August, a member of Gulnare Free Will Baptist Church told Harville's father that Chikuni couldn't sing there anymore. And last Sunday, in a moment that seems from another time, church members voted 9-6 to bar mixed-race couples from joining the congregation.
The policy has drawn a firestorm of criticism in just a few days and sent church leaders scrambling to overturn it, perhaps as early as Sunday. The executive secretary of the church's national organization said he has been inundated with angry phone calls, and had an inch-high stack of emails printed out on his desk.
"We are not a group of racist people," said Keith Burden of the National Association of Free Will Baptists. "We have been labeled that obviously because of the actions of nine people."
The resolution approved by the Gulnare church says it does not condone interracial marriage and "parties of such marriages will not be received as members, nor will they be used in worship services and other church functions, with the exception being funerals."
Ballots were cast after the service, attended by about 35 to 40 people, but it wasn't clear why so few people voted.
The church member and former pastor who pushed for the vote, Melvin Thompson, wouldn't tell The Associated Press why he did it.
"I am not racist. I will tell you that. I am not prejudiced against any race of people, have never in my lifetime spoke evil" about a race, Thompson said earlier this week in a brief interview. "That's what this is being portrayed as, but it is not."
Thompson stepped down as pastor earlier this year for health reasons, according to Harville's dad, Dean Harville. He said it was Thompson who told him that Chikuni couldn't sing at the church, a small, one-story red brick building with few windows and a white steeple.
After giving interviews earlier this week, the church's current pastor, Stacy Stepp, and several other church members did not return phone calls Friday. One of the members said they were shocked. Stepp said he voted against the measure and would work to overturn it.
The national group distanced itself from the resolution in a statement Thursday, saying it "neither condemns nor disallows" interracial marriage.
It said the church was working to reverse its policy and added, "We encourage the church to follow through with this action."
Harville, who is now engaged to Chikuni, said earlier this week that she felt betrayed by the church.
"Whether they keep the vote or overturn it, it's going to be hard for me go back there," she told AP.
Gulnare is a small town in Pike County, in eastern Kentucky. The county celebrates its Appalachian heritage in the spring with the Hillbilly Days Festival in downtown Pikeville, the county seat, and the Apple Blossom Festival in Elkhorn City, according to a tourism website.
Harville is working on her master's degree in optical engineering at an Indiana college. She met Chikuni, who is from Zimbabwe, at Georgetown College in central Kentucky.
"It's like we were kind of blindsided," Harville said of the church's action.
More than 40 years ago, the U.S. Supreme Court knocked down a Virginia statute barring whites from marrying nonwhites, overturning bans in 15 other states. But while interracial marriages have soared since then, many churches remain largely segregated.
Curtiss Paul DeYoung, a professor at Bethel College who has studied interracial churches, said church members opposed to a more diverse church usually just go somewhere else.
"Rarely today do you see it so blatantly come to a vote. Usually people just leave but they don't say much about it," DeYoung said. "I think this is still one of the last hurdles around race for a lot of folks in this country. It's just rarely stated this bluntly."
The Free Will Baptists trace their history to the 18th century. They emphasized the Arminian doctrine of free will, free grace, and free salvation, in contrast to most Baptists, who were Calvinists and believed Christ died only for those predestined to be saved.
There are some 4,200 churches worldwide. The National Association of Free Will Baptists organized in Nashville, Tenn., in 1935 and is now based in Antioch, Tenn.
The group said in its statement that the denomination has no official policy regarding interracial couples "because it has not been an issue."
war in iraq war in iraq gunner kiel gunner kiel baby lisa baby lisa paranormal activity
Friday, December 2, 2011
Yale researchers develop a way to monitor engineered blood vessels as they grow in patients
![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
Public release date: 30-Nov-2011[ | E-mail |
Share ] Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
New research in the FASEB Journal suggests magnetic resonance imaging allows researchers to study and monitor how new vessels perform while they are 'under construction' in patients
Bethesda, MDUsing magnetic resonance imaging (MRI) and nanoparticle technology, researchers from Yale have devised a way to monitor the growth of laboratory-engineered blood vessels after they have been implanted in patients. This advance represents an important step toward ensuring that blood vessels, and possibly other tissues engineered from a patient's own biological material, are taking hold and working as expected. Until now, there has been no way to monitor the growth and progress of engineered tissues once they were implanted. This research was published in the December 2011 issue of the FASEB Journal (http://www.fasebj.org).
"We hope that the important findings from our study will serve as a valuable tool for physicians and scientists working to better understand the biological mechanisms involved in tissue engineering," said Christopher K. Breuer, M.D., co-author of the study from the Interdepartmental Program in Vascular Biology and Therapeutics at Yale University School of Medicine in New Haven, CT. "Resulting advances will hopefully usher in a new era of personalized medical treatments where replacement vessels are specifically designed for each patient suffering from cardiac anomalies and disease."
To make this advance, scientists used two different groups of cells to make tissue-engineered blood vessels. In the first group, the cells were labeled with the MRI contrast agent. In the second group, the cells were normal and did not have an MRI label. Cells from each group were then used to create separate laboratory-engineered blood vessels, which were implanted into mice. The purpose was to see whether the laboratory-engineered blood vessels made from cells that were labeled with the contrast agent would indeed be visible on MRI and to make sure that the addition of the contrast agent did not negatively affect the cells or the function of the laboratory-engineered vessels. Researchers imaged the mice with MRI and found that it was possible to track the cells labeled with contrast agent, but not possible to track the cells that were not labeled. This suggests that using MRI and cellular contrast agents to study cellular changes in the tissue-engineered blood vessels after they are implanted is an effective way to monitor these types of vessels.
"This is great news for patients with congenital heart defects, who have to undergo tissue grafting, but that's only the tip of the scalpel," said Gerald Weissmann, M.D., Editor-in-Chief of the FASEB Journal. "As we progress toward an era of personalized medicinewhere patients' own tissues and cells will be re-engineered into replacement organs and treatmentswe will need noninvasive ways to monitor what happens inside the body in real time. This technique fulfills another promise of nanobiology."
###
Receive monthly highlights from the FASEB Journal by e-mail. Sign up at http://www.faseb.org/fjupdate.aspx. The FASEB Journal (http://www.fasebj.org) is published by the Federation of the American Societies for Experimental Biology (FASEB) and celebrates its 25th anniversary in 2011. Over the past quarter century, the journal has been recognized by the Special Libraries Association as one of the top 100 most influential biomedical journals of the past century and is the most cited biology journal worldwide according to the Institute for Scientific Information.
FASEB comprises 24 societies with more than 100,000 members, making it the largest coalition of biomedical research associations in the United States. FASEB enhances the ability of scientists and engineers to improvethrough their researchthe health, well-being and productivity of all people. FASEB's mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.
Details: Jamie K. Harrington, Halima Chahboune, Jason M. Criscione, Alice Y. Li, Narutoshi Hibino, Tai Yi, Gustavo A. Villalona, Serge Kobsa, Dane Meijas, Daniel R. Duncan, Lesley Devine, Xenophon Papademetri, Toshiharu Shin'oka, Tarek M. Fahmy, and Christopher K. Breuer.
Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI.
FASEB J. December 2011 25:4150-4161; doi:10.1096/fj.11-185140 ; http://www.fasebj.org/content/25/12/4150.abstract
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Public release date: 30-Nov-2011[ | E-mail |
Share ] Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
New research in the FASEB Journal suggests magnetic resonance imaging allows researchers to study and monitor how new vessels perform while they are 'under construction' in patients
Bethesda, MDUsing magnetic resonance imaging (MRI) and nanoparticle technology, researchers from Yale have devised a way to monitor the growth of laboratory-engineered blood vessels after they have been implanted in patients. This advance represents an important step toward ensuring that blood vessels, and possibly other tissues engineered from a patient's own biological material, are taking hold and working as expected. Until now, there has been no way to monitor the growth and progress of engineered tissues once they were implanted. This research was published in the December 2011 issue of the FASEB Journal (http://www.fasebj.org).
"We hope that the important findings from our study will serve as a valuable tool for physicians and scientists working to better understand the biological mechanisms involved in tissue engineering," said Christopher K. Breuer, M.D., co-author of the study from the Interdepartmental Program in Vascular Biology and Therapeutics at Yale University School of Medicine in New Haven, CT. "Resulting advances will hopefully usher in a new era of personalized medical treatments where replacement vessels are specifically designed for each patient suffering from cardiac anomalies and disease."
To make this advance, scientists used two different groups of cells to make tissue-engineered blood vessels. In the first group, the cells were labeled with the MRI contrast agent. In the second group, the cells were normal and did not have an MRI label. Cells from each group were then used to create separate laboratory-engineered blood vessels, which were implanted into mice. The purpose was to see whether the laboratory-engineered blood vessels made from cells that were labeled with the contrast agent would indeed be visible on MRI and to make sure that the addition of the contrast agent did not negatively affect the cells or the function of the laboratory-engineered vessels. Researchers imaged the mice with MRI and found that it was possible to track the cells labeled with contrast agent, but not possible to track the cells that were not labeled. This suggests that using MRI and cellular contrast agents to study cellular changes in the tissue-engineered blood vessels after they are implanted is an effective way to monitor these types of vessels.
"This is great news for patients with congenital heart defects, who have to undergo tissue grafting, but that's only the tip of the scalpel," said Gerald Weissmann, M.D., Editor-in-Chief of the FASEB Journal. "As we progress toward an era of personalized medicinewhere patients' own tissues and cells will be re-engineered into replacement organs and treatmentswe will need noninvasive ways to monitor what happens inside the body in real time. This technique fulfills another promise of nanobiology."
###
Receive monthly highlights from the FASEB Journal by e-mail. Sign up at http://www.faseb.org/fjupdate.aspx. The FASEB Journal (http://www.fasebj.org) is published by the Federation of the American Societies for Experimental Biology (FASEB) and celebrates its 25th anniversary in 2011. Over the past quarter century, the journal has been recognized by the Special Libraries Association as one of the top 100 most influential biomedical journals of the past century and is the most cited biology journal worldwide according to the Institute for Scientific Information.
FASEB comprises 24 societies with more than 100,000 members, making it the largest coalition of biomedical research associations in the United States. FASEB enhances the ability of scientists and engineers to improvethrough their researchthe health, well-being and productivity of all people. FASEB's mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.
Details: Jamie K. Harrington, Halima Chahboune, Jason M. Criscione, Alice Y. Li, Narutoshi Hibino, Tai Yi, Gustavo A. Villalona, Serge Kobsa, Dane Meijas, Daniel R. Duncan, Lesley Devine, Xenophon Papademetri, Toshiharu Shin'oka, Tarek M. Fahmy, and Christopher K. Breuer.
Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI.
FASEB J. December 2011 25:4150-4161; doi:10.1096/fj.11-185140 ; http://www.fasebj.org/content/25/12/4150.abstract
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Source: http://www.eurekalert.org/pub_releases/2011-11/foas-yrd113011.php
little big town bennett bennett daniel day lewis patti stanger pasadena pasadena
Monday, November 28, 2011
Local economic development team presents jobs plans in Albany (Rochester Democrat and Chronicle)
Subscribe to:
Comments (Atom)